| This article has been cited by |
| 1 | Pharmacological treatment of diabetes in older people | |
| W. M. Valencia,H. Florez |
| Diabetes, Obesity and Metabolism.2014;16(12)1192 |
| [DOI] |
|
| 2 | Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities | |
| Mohd Faizan,Alika Sarkar,Mahendra Pratap Singh |
| Ageing Research Reviews.2022;81(12)101727 |
| [DOI] |
|
| 3 | Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities | |
| Alexander Olegovich Shpakov |
| Ageing Research Reviews.2018;81(12)101727 |
| [DOI] |
|
| 4 | Influence of Bromocriptine Plus Metformin Treatment on Glycaemia and Blood Pressure in Patients with Type 2 Diabetes Mellitus | |
| Alfredo Briones-Aranda,Javier Ramírez-Carballo,Bernardo Alfredo Romero Gómez,Victor Manuel Vega Villa,Manuela Castellanos Pérez,Esmeralda Garcia Parra,Hugo Roberto Santeliz-Montero |
| Romanian Journal of Diabetes Nutrition and Metabolic Diseases.2018;25(1)59 |
| [DOI] |
|
| 5 | The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials | |
| Ida Brandt Andersen,Mikkel Andreassen,Jesper Krogh |
| Diabetes, Obesity and Metabolism.2021;23(1)58 |
| [DOI] |
|
| 6 | Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus | |
| Maka Siamashvili,Stephen Davis |
| Expert Opinion on Pharmacotherapy.2021;22(2)241 |
| [DOI] |
|
| 7 | Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review | |
| Fauze Camargo Maluf,David Feder,Alzira Alves de Siqueira Carvalho |
| Parkinson's Disease.2019;2019(2)1 |
| [DOI] |
|
| 8 | Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus | |
| Stanley S. Schwartz,Farhad Zangeneh |
| Postgraduate Medicine.2016;128(8)828 |
| [DOI] |
|
| 9 | Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus | |
| Md. Tanvir Kabir,Jannatul Ferdous Mitu,Raushanara Akter,Muhammad Furqan Akhtar,Ammara Saleem,Ahmed Al-Harrasi,Saurabh Bhatia,Md. Sohanur Rahman,Fouad Damiri,Mohammed Berrada,Md. Habibur Rahman |
| Environmental Science and Pollution Research.2022;29(31)46385 |
| [DOI] |
|
| 10 | Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases | |
| Alexander O Shpakov,Kira V Derkach,Lev M Berstein |
| Future Science OA.2015;1(3)46385 |
| [DOI] |
|
